Introduction
============

The increased incidence of adrenal incidentaloma (AI) is mostly due to advancements in imaging techniques and increases in the volume of cross-sectional imaging carried out. The term AI refers to an incidentally identified adrenal mass greater than 1 cm in diameter during an imaging examination performed for reasons other than the evaluation of adrenal glands. Histologically, the most common AIs are adrenal adenoma (41%-52%), followed by metastatic diseases (19%), adrenocortical carcinoma (5-10%), myelolipoma (9%) and pheochromocytoma (8%) [@B1], [@B2]. When selecting optimal adrenal imaging modalities, computed tomography (CT) is one of the most widely chosen tools [@B3].

An AI is easily identified if it has certain diagnostic features. A cyst presents as a well-defined homogenous round mass without enhancement, and a myelolipoma has macroscopic fat deposits that are detectable on a CT scan. If an adenoma exhibits low density on a plain CT scan with CT attenuation values lower than 10 Hounsfield units (HU), it can be diagnosed with confidence (sensitivity of 71% and specificity of 98%) and is referred to as a fat-rich adenoma [@B4]. However, it remains difficult for radiologists and surgeons to differentiate some pheochromocytomas from lipid-poor adenomas (LPAs, those with CT attenuation values over 10 HU) because the imaging features for both conditions largely overlap [@B5]-[@B9]. Pheochromocytomas have a variable appearance on imaging, and some atypical pheochromocytomas that lack typical imaging characteristics can be easily misdiagnosed as adenomas, especially as LPA.

Generally, an incidentally detected pheochromocytoma is asymptomatic and termed "subclinical pheochromocytoma (sPHEO)". Although a sPHEO is usually clinically silent, it maintains secretory function. Failing to differentiate such pheochromocytomas from other tumors before surgery or biopsy may lead to a life-threatening crisis because these interventions may stimulate the tumor and result in an adrenergic storm [@B5], [@B9]. Therefore, identifying the possibility of this disease is of vital importance for avoiding potential catastrophic consequences and guiding further treatments. Thus, the ability to distinguish sPHEO from LPA is a worthwhile goal. However, making this distinction in conventional imaging analysis has been impossible thus far.

Quantitative texture analysis (QTA) refers to the process of converting digital medical images into high-dimensional, mineable data via high-throughput extraction of quantitative descriptors, followed by subsequent data analysis and model building for improved decision-making support [@B10]-[@B12]. The recent results of QTA are promising in oncological practice, including tumor discrimination and subtype classification, as well as treatment response assessments [@B11], [@B13]-[@B16]. To the best of our knowledge, no previously published study has determined whether QTA can be applied to differentiate sPHEO from LPA in AI. Therefore, we wondered whether QTA could play an important role in making this distinction on unenhanced CT scans. The goal of our study was to determine the feasibility and accuracy of using machine learning-based QTA in differentiating sPHEO from LPA in AI on unenhanced CT images.

Materials and methods
=====================

Patients
--------

Ethical approval was obtained from Institutional Review Board of our Hospital, and written informed consents were waived for this retrospective study.

Our study was carried in accordance with relevant guidelines and regulations. Between January 2013 to June 2016, all patients with surgically and pathologically confirmed sPHEO or adrenal adenoma were retrieved from the medical database of our hospital. Inclusion criterion was AI identified during an imaging examination performed for reasons other than the evaluation of adrenal glands. The exclusion criteria were (1) no preoperational CT images available; (2) existing unenhanced CT scan displaying a fat-rich adenoma for patients with adrenal adenoma, (3) adrenal lesion showing enhancement of greater than 100 HU on a CT scan for patients with pheochromocytoma; (4) no enhancement found in the lesion for patients with adrenal adenoma; and (5) CT performed on other machines other than 320-MDCT scanner (Aquilion ONE, Toshiba, Otawara, Japan). According to the inclusion/exclusion criteria (shown in Supplementary files), 80 LPAs (79 patients) and 30 sPHEOs (29 patients) were ultimately enrolled in the present study.

Imaging technique
-----------------

All patients underwent a uniform CT scanning protocol on a 320-multiple detector computed tomography (MDCT) scanner (Aquilion ONE, Toshiba, Otawara, Japan). After routine nonenhanced CT, arterial and portal venous-phase contrast-enhanced CT scans were performed, with fixed delay times of 28 s and 60 s, respectively, followed by intravenous administration of 90 - 100 ml of iodinated contrast material Ultravist 370 (Bayer Schering Pharma, Berlin, Germany) at a rate of 3.0 - 3.5 ml/s for adults and 1.0 - 1.5 ml/s for children using a power injector (Ulrich CT plus 150, Ulrich Medical, Ulm, Germany). The precontrast and contrast-enhanced CT images were reconstructed with a thickness of 1 mm. The scanning parameters are listed in Supplementary table [1](#SM0){ref-type="supplementary-material"}.

Imaging analysis
----------------

Images for each patient were reviewed by three abdominal radiologists with 8, 7 and 13 years of experience, who were blinded to patient information, including the pathological diagnosis. The radiologists independently evaluated tumor shape, size, margin and heterogeneity, the presence of calcification and the CT attenuation value of the tumor. The findings were recorded by consensus.

QTA features exaction, selection and texture analysis
-----------------------------------------------------

Details about QTA features exaction, selection and texture analysis were shown in supplementary files. Briefly, QTA features exaction was performed by using texture analysis software (MaZda Version 4.6, Institute of Electronics, Technical University of Lodz, Poland) [@B17]. Feature analysis was carried out using the B11 (version 3.3) application of MaZda. CT images processing [@B18], QTA features exaction, selection and texture analysis [@B19], as well as intra-observer (reader 1 twice) and interobserver (reader 1 v reader 2) reproducibility evaluations, can be found in the Supplementary files.

Development of an equation for differentiating sPHEO from LPA
-------------------------------------------------------------

Logistic multiple regression analysis was performed using the 30 texture features selected in the above steps. We ultimately identified 4 texture features with good diagnostic accuracy when combined. Regression coefficients obtained for each texture feature were used to create an equation.

Statistical analysis
--------------------

Statistical analyses were performed using SPSS (version 19, IBM), and a *P* value \< 0.05 was considered significant. Quantitative data with a normal distribution are presented as the means ± SD, and the groups were compared using independent Student\'s *t* test. Quantitative data with a non-normal distribution are presented as medians (interquartile ranges), and the groups were compared using a Wilcoxon rank-sum test. Patient sex ratios and lesion location ratios between the two groups were compared using a chi-square test. Receiver operating characteristic (ROC) curves were used to analyze the predictive value of every feature and compare the predictive value of the number of positive features and the equation.

Results
=======

Clinical characteristics
------------------------

Demographic information and CT scan characteristics of the analyzed tumors are presented in Table [1](#T1){ref-type="table"}.

Age was significantly different between patients with LPAs (48 ± 12 years) and those with sPHEOs (42 ± 15 years) (*P* = 0.047). SPHEOs were significantly larger than LPAs (5.4 ± 2.2 cm vs 2.7 ± 1.8 cm) (*P* \< 0.001). The mean unenhanced CT attenuation value of sPHEOs was significantly higher than that of LPAs (37.2 ± 7.4 HU and 24.5 ± 9.9 HU respectively, *P* \< 0.001), and there was a significant difference in the location ratio among them (*P* = 0.002). There was no significant difference between the sex ratios of patients with either type of lesion (*P* = 0.141).

Feature selection and texture analysis
--------------------------------------

Satisfactory inter- and intra-observer reproducibility of QTA features extraction was achieved. The interobserver intraclass correlation coefficients (ICCs) between reader 1 (first time) and reader 2 ranged from 0.754 to 0.855. The intra-observer ICC between reader 1\'s twice feature extraction ranged from 0.792 to 0.893. Therefore, the features extracted by reader 1 were selected for subsequent analysis.

A total of 30 texture features were selected from 377 original parameters produced from all patient scans. This resulted in a misclassification rate of 19.39% for differentiating sPHEOs from LPA on unenhanced CT images using LPA (Figure [1](#F1){ref-type="fig"}).

Wilcoxon rank sum tests revealed that all 30 texture features were significantly different between sPHEO and LPA (*P* \< 0.05) (Supplementary table [2](#SM0){ref-type="supplementary-material"}). ROC curve analyses of the 30 texture features showed that all features had a good accuracy for making a differential diagnosis of sPHEO and LPA with a concordance rate greater than 80%, except for S(5,5)SumAverg, S(0,5)SumAverg and S(5,-5)Correlat (Supplementary table [3](#SM0){ref-type="supplementary-material"}).

Geo W6, GeoW13, S(5,5)SumAverg, WavEnHL_s-3 and S(0,5)SumAverg were considered positive if their values were less than their cutoff points. For the remaining features, values greater than the cutoff point were considered positive. We used the number of positive features as a predictor. When the number of positive features exceeded 8, the accuracy of prediction was 85.2% (92/108), with a sensitivity of 96.6% (28/29) and a specificity of 81% (64/79) (Supplementary table [4](#SM0){ref-type="supplementary-material"}).

Development of a prediction equation
------------------------------------

To screen for the most reliable independent features, we performed a logistic multiple regression analysis of the 30 features. The inclusion criterion was a *P* \< 0.010, and the exclusion criterion was a *P*\>0.05. Finally, GeoFmin, GeoS, 135dr_GLevNonU and GeoEr had a good diagnostic accuracy when combined (Table [2](#T2){ref-type="table"}). The regression coefficients obtained for each feature were used for the construction of an equation to calculate a value, denoted *P*, to assess the nature of a lesion based on the given texture feature values:

*P* values greater than or equal to 0.5 and less than 1 suggest sPHEO, and *P* values greater than 0 and less than 0.5 indicate LPA.

Next, a back-substitution check was performed. This equation had a predictive accuracy of 94.4% (102/108), with a sensitivity of 86.2% (25/29) and a specificity of 97.5% (77/79) in differentiating sPHEO from LPA (Table [3](#T3){ref-type="table"}).

The predictive values of two methods, using the number of positive features or the equation, were compared using ROC curves. The area under the ROC curve for the equation-based method was 0.952 (0.897-1.000), which was slightly greater than that of the method using the number of positive features (0.917, 0.8946-0.988). However, there was no significant difference between these areas (*P* \>0.05) (Figure [2](#F2){ref-type="fig"}).

Discussion
==========

Although AI is a common clinical entity [@B1], [@B2], [@B20], [@B21], it remains challenging to classify AIs if the tumors do not have typical imaging features. Among AIs, sPHEOs have been termed imaging "chameleons" due to their various imaging features that may mimic other lesions, such as LPA [@B6]-[@B8], [@B22], [@B23]. CT washout protocols are not reliable for differentiating sPHEO from LPA [@B6]-[@B8], [@B22]. Moreover, recognizing a sPHEO preoperatively is of vital importance because the presence of a sPHEO does not exclude the possibility of a hypertensive crisis [@B24], [@B25]. However, the problem of distinguishing sPHEOs from LPAs remains unsolved. In the present study, we introduce a new method termed machine learning-based QTA, which converts images into higher dimensional data and mines these data, to address this problem. As expected, both our equation and the number of positive features derived from our analysis represent the first demonstration of an effective method to differentiate sPHEO from LPA, revealing the clinical significance of this type of analysis.

In our study, the unenhanced CT attenuation values of sPHEOs were significantly greater than those of LPAs. The minimum unenhanced CT attenuation value of a sPHEO is 23 HU; therefore, none of the sPHEOs imaged in our study could be confused for a lipid-rich adenoma. This result is in accordance with the findings of Patel et al and Motta-Ramirez et al [@B8], [@B26]

Our results show that the new method can differentiate sPHEO from LPA based on unenhanced CT images. According to our data, the classification accuracy was approximately 80% using LPA. Yan et al divided the classification results into several levels according to the misclassification rates in differentiating angiomyolipoma with minimal fat from renal cell carcinoma: excellent (misclassification rates ≤ 10%), good (10% \< misclassification rate ≤ 20%), moderate (20% \< misclassification rates ≤ 30%), fair (30% \< misclassification rates ≤ 40%), and poor (misclassification rates ≥ 40%) [@B16]. According to these criteria, our method resulted in good classification rates for sPHEO versus LPA.

Our study provides reliable solutions for differentiating sPHEO from LPA on unenhanced CT scans. Both methods applied in this study yielded good results. When the number of positive features exceeded 8, the accuracy of prediction was 85.2% (92/108), with a sensitivity of 96.6% (28/29) and a specificity of 81% (64/79). The equation had a predictive accuracy rate of 94.4% (102/108), with a sensitivity of 86.2% (25/29) and a specificity of 97.5% (77/79) in differentiating sPHEO from LPA. The score of an adrenal lesion is easily obtained using the equation presented here, which includes the following QTA features: GeoFmin, GeoS, 135dr_GLevNonU and GeoEr. Furthermore, the calculation can be performed with a computer, making it easy for radiologists and surgeons to obtain results that are more accurate than their subjective judgments.

Although contrast-enhanced CT images were also available, we restricted our analysis to unenhanced CT images because we wanted to know if such analysis based on unenhanced CT images only is adequate for making a satisfactory distinction. If this analysis truly works, then it will help prevent unnecessary enhanced CT scans. In addition, the reliability of such analysis is closely related to the source of original data. Data extracted from unenhanced CT scans are much simpler than those extracted from enhanced CT scans as unenhanced CT images depend only on the inherent density of the tumor, while enhanced CT images are affected by many other factors, including differences in contrast materials and injection rate, as wells as the scan delay time. Unenhanced CT is easier to control, and the scans are easier to obtain. Additionally, in our study, we extracted all QTA features from the same CT scanner at our institution to reduce bias and variance. In a study by Ganeshan et al [@B27], significant textural differences in both nonenhanced and contrast-enhanced lung cancer CT images were identified. However, whether iodine contrast affects CT-based QTA remains unclear. Studies regarding the influence of enhancement on QTA are lacking, and further research may be needed to address this problem.

This study had several limitations that may have influenced the results. There was a large discrepancy between the sample sizes for the two groups due to the difference in the relative incidence of the two types of lesions, as well as the strict exclusion criteria used in our study. The retrospective nature of the study may have also resulted in a number of limitations, including subject selection bias. In the future, a well-designed prospective study with enough cases should be carried out to test the reliability of our equation. In addition, due to the relatively small size of our study population, we did not divide our data into training and test datasets.

Conclusion
==========

Based on unenhanced CT images, our results suggest that machine learning-based QTA is a feasible method for differentiating sPHEO from LPA when AI is present.
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Supplementary figure, tables and methods.
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Click here for additional data file.
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![Differentiating sPHEO from lipid-poor adenoma based on a dataset including all patients. Misclassification rate was 19.39% from a LPA of unenhanced CT scans. Classification results are represented graphically as the relationship between the most discriminating factors (MDFs). MDF 1, MDF 2 and MDF 3 are the most discriminating feature axes used in the LPA to represent the classification.](jcav09p3577g001){#F1}

![ROC curves of the two predictive methods. Total score represents the number of positive features. Predicted probability represents the equation.](jcav09p3577g002){#F2}

###### 

Characteristics of patients with LPA or sPHEO

  ------------------------------------------------------------
  Characteristics            LPA         sPHEO      P value
  -------------------------- ----------- ---------- ----------
  Sex                                               P=0.141

  Men                        37          9          

  Women                      42          20         

  Age (y)                    48±12       42±15      P=0.047

  Lesion size (mm)           26.5±18.2   53.6±22    P\<0.001

  Location                                          

  Left                       46          8          P=0.009

  Right\                     32\         20\        
  Both                       1           1          

  Unenhanced CT value (HU)   24.5±9.9    37.2±7.4   P\<0.001
  ------------------------------------------------------------

###### 

Logistic multiple regression analysis results

  Features         Regression coefficient (B)   Standard error   Chi-square value   *P* value   Exp (B)
  ---------------- ---------------------------- ---------------- ------------------ ----------- ---------
  GeoFmin          0.624                        0.239            6.850              0.009       1.867
  GeoS             -0.636                       0.205            9.668              0.002       0.529
  135dr_GLevNonU   -0.051                       0.019            6.927              0.008       0.950
  GeoEr            0.731                        0.298            6.023              0.014       2.077
  Constant         -8.728                       1.947            20.088             0.000       0.000

###### 

Predictive effect of the equation

  Observed value                 Predictive value   Total   
  ------------------------------ ------------------ ------- -----
  Fat-poor adenoma               77                 2       79
  Subclinical pheochromocytoma   4                  25      29
  Total                          81                 27      108
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